PPH peer analysis
VanEck Pharmaceutical (PPH) against its competitors: price, today's move, 1-year return and market value side by side.
PPH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBH VanEck Biotech | $255.57 | 0.42% | 44.52% | – |
| BKMC Mid Cap Core | $39.54 | 0.77% | 10.44% | – |
| CXSE WisdomTree China ex-SOE | $31.31 | 0.22% | -28.53% | – |
| EBI Longview Advantage | $66.32 | -1.49% | 18.86% | – |
| FYC Small Cap Growth | $113.52 | 0.59% | 19.62% | – |
| IHE US Pharmaceuticals | $106.72 | -0.19% | 39.80% | – |
| NUKZ Nuclear Renaissance | $57.12 | 1.24% | -21.33% | – |
| OSEA Harbor International Compounders ETF | $29.69 | -0.67% | -2.37% | – |
| SGDM Sprott Gold Miners | $65.27 | -1.97% | 12.02% | – |
| VNM VanEck Vietnam | $16.46 | 0.37% | -3.69% | – |
| PPH VanEck Pharmaceutical | $122.02 | 2.88% | 31.43% | – |
- PPH's peers: BBH (VanEck Biotech), BKMC (Mid Cap Core), CXSE (WisdomTree China ex-SOE), EBI (Longview Advantage), FYC (Small Cap Growth), IHE (US Pharmaceuticals), NUKZ (Nuclear Renaissance), OSEA (Harbor International Compounders ETF).
Updated 2026-11-04 22:35 UTC